Sepsis, Systemic Inflammatory Response Syndrome, Multiple Organ Dysfunction Syndrome, and Multiple Organ Failure: are Trauma Surgeons Lumpers or Splitters?

Journal of Trauma

Volumn 55, Issue 5, 2003, Pages 997-998

  Baue, Arthur E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE;

DISEASE CLASSIFICATION; HUMAN; IMMUNE RESPONSE; MULTIPLE ORGAN FAILURE; NOTE; PRIORITY JOURNAL; SEPSIS; SURGEON; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERMAL INJURY; TRAUMATOLOGY;

HUMANS; MULTIPLE ORGAN FAILURE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERMINOLOGY;

EID: 0346903003     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000094631.54198.07     Document Type: Editorial

References (20)

1. One lumper or two? The Scientist. 2002; 16: 12.
2. Societies begin battle on sepsis. Crit Connections. 2003; February.
3. ACCP/SCCM Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20: 864-874.
4. Baue AE. MODS, MOF: a complication of progress in organ support. Shock. 2000; 13: 7-18.
5. Opal SM. Clinical trials for severe sepsis: past failures and future hopes. Infect Dis Clin North Am. 1999; 13: 285-297.
6. Eidelman LA, Sprung CL. Why have new effective therapies for sepsis not been developed? Crit Care Med. 1994; 22: 1330-1334.
7. Bone RC. Why sepsis trials fail. JAMA. 1996; 276: 565-566.
8. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med. 1997; 25: 1095-1100.
9. Baue AE. MOF, MODS and SIRS: why no magic bullets? Arch Surg. 1997; 132: 703-707.
10. Moore FD. Metabolic Care of the Surgical Patient. Philadelphia: WB Saunders; 1959.
11. Stehbens WE. The concept of cause in disease. J Chronic Dis. 1985; 38: 947-950.
12. Knox J, Demling R, Wilmore D, et al. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J Trauma. 1995; 39: 526-532.
13. Takala J, Ruokonen E, Webster WR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med. 1999; 341: 785-792.
14. Luiten EJT, Wim CJ, Lange JF, et al. Controlled clinical trial of selected decontamination for the treatment of severe acute pancreatitis. Ann Surg. 1995; 222: 57-65.
15. Lingnau W, Berger J, Javorsky F, Benzer H. Selective gut decontamination in multiple trauma patients: a prospective randomized trial. J Trauma. 1997; 42: 687-694.
16. Baue AE. Multiple organ failure, multiple organ dysfunction syndrome and systemic inflammatory response syndrome: why no magic bullets? Arch Surg. 1997; 132: 703-707.
17. Baue AE. Ongoing challenges in sepsis and organ dysfunction. In:APICE-2003: International Symposium on Critical Care Medicine, November 14-18, 2003. Milano: Springer (in press).
18. Baue AE. A debate on the subject “Are SIRS and MODS important entities in the clinical evaluation of patients?” The con position. Shock. 2000; 14: 590-593.
19. Baue AE. Bad and good news in prevention and management of sepsis and MODS. Minerva Anestesiol. 2001; 67: 773-783.
20. Baue AE. Multiple organ failure in this new millennium. Crit Care Shock. 2001; 1: 1-9.